Application of dsRNA or modification thereof in preparation of tumor inhibitor

The invention discloses an application of a dsRNA (Double-stranded RNA) or a modification thereof in preparation of a tumor inhibitor. According to the application, the sequence of one strand of the dsRNA is SEQ ID No. 1 in the sequence table, and the sequence of the other strand of the dsRNA is SEQ...

Full description

Saved in:
Bibliographic Details
Main Authors XIE WEIDONG, WU JIANGBIN, WANG JIU, ZHANG YAOU, HE JIE, XU NAIHAN
Format Patent
LanguageChinese
English
Published 19.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses an application of a dsRNA (Double-stranded RNA) or a modification thereof in preparation of a tumor inhibitor. According to the application, the sequence of one strand of the dsRNA is SEQ ID No. 1 in the sequence table, and the sequence of the other strand of the dsRNA is SEQ ID No. 2 in the sequence table; the modification of the dsRNA is the dsRNA modification obtained by being modified through the steps of A1), A2) or A3) as follows: A1) modifying 2'-OH of the ribose of the dsRNA; A2) modifying the phosphate diester bond, used for being connected with the ribotide, of the dsRNA; A3) modifying the cholesterol connected with the 5' end of the ribose of the dsRNA. Experimental results show that the 2'-OMe-dsRNA21 or the modification thereof can effectively inhibit tumor and tumor cells.
Bibliography:Application Number: CN20141383877